Michael Tainsky - Southfield MI, US Madhumita Chatterjee - Lake Orion MI, US Gregory Dyson - Northville MI, US Nancy Levin - Birmingham MI, US
Assignee:
Wayne State University - Detroit MI
International Classification:
G01N 33/574 C07K 16/32 G01N 33/564
Abstract:
Polypeptide marker antigens for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, each of the polypeptide marker antigens binding specifically to at least one autoantibody marker. An antibody binding assay for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, and methods for performing the assay. Methods for determining ovarian cancer recurrence in an ovarian cancer patient. A method for isolating antibodies specific for ovarian cancer by their affinity to the polypeptide marker antigens, and antibodies isolated by that method.
Detectors Of Serum Biomarkers For Predicting Ovarian Cancer Recurrence
Michael Tainsky - Southfield MI, US Madhumita Chatterjee - Lake Orion MI, US Gregory Dyson - Northville MI, US Nancy Levin - Birmingham MI, US
Assignee:
Wayne State University - Detroit MI
International Classification:
G01N 33/574 C07K 14/47
Abstract:
Polypeptide marker antigens for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, each of the polypeptide marker antigens binding specifically to at least one autoantibody marker. An antibody binding assay for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, and methods for performing the assay. Methods for determining ovarian cancer recurrence in an ovarian cancer patient. A method for isolating antibodies specific for ovarian cancer by their affinity to the polypeptide marker antigens, and antibodies isolated by that method.
Detectors Of Serum Biomarkers For Predicting Ovarian Cancer Recurrence
Polypeptide marker antigens for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, each of the polypeptide marker antigens binding specifically to at least one autoantibody marker. An antibody binding assay for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, and methods for performing the assay. Methods for determining ovarian cancer recurrence in an ovarian cancer patient. A method for isolating antibodies specific for ovarian cancer by their affinity to the polypeptide marker antigens, and antibodies isolated by that method.
Rita Kilcoyne, Ann Kelly, Margo Stults, Jay Arbetman, Howard Mack, Kathy Klotz, Julie Henke, Bill Abell, Connie Tallman, Virginia Leider, Steve Kammann
Biography:
After GBN I went to NIU then transferred to UofA in Tucson. It was there that I ran ...